Font Size: a A A
Keyword [Highly active antiretroviral therapy]
Result: 41 - 60 | Page: 3 of 4
41. The Clinical Research Of Fu Fang Qi Shu Decoction Combined With Highly Active Antiretroviral Therapy Treating Aids In Type Of Spleen-insufficiency With Dampness- Overabundance
42. Analysis Of Effect On Early Highly Active Antiretroviral Therapy And Influencing Factors Among HIV-infected Adults In Yili, Xinjiang
43. Research On Factors Associated With Adherence Of Highly Active Antiretroviral Therapy Among HIV/AIDS Patients
44. Impact Of Long-term Highly Active Antiretroviral Therapy On Metabolism In AIDS Patients
45. Study On Data Mining Based Personalized Treatment Strategy For AIDS Patients
46. Clinical Significance Of Changes Of HCY And LEP Levels In Serum Of HIV-infected Patients Receiving Highly Active Antiretroviral Therapy
47. Study On The Status Of Antiviral Therapy For AIDS Patients In Jinan City
48. Research On Lipometabolism Disorder Due To Antiviral Therapy With Lopinavir/Ritonavir In AIDs Patients
49. The Study On The Epidemiological Characteristics And Liver Damage During HARRT Treatment Of Adult Patients With HIV/AIDS
50. Study On HIV Drug Resistance And Hair Drug Concentration Detection Methods In Antiviral Treatment Population
51. Study Of Survivai Time And Treatment Effect And Influence Factors After Highly Active Antiretroviral Therapy For HIV/AIDS Patients In Guangxi Guigang
52. The Effect Of Highly Active Antiretroviral Therapy(HARRT) On The Prevalence Of HBV Drug Resistance Mutations In HIV/HBV Co-infected Patients
53. The Composition Of Intestinal Microbita And Immune System In AIDS Patients On Long-term Highly Active Antiretroviral Therapy
54. Clinical Significance Of Low Level Viremia In HIV-1 Infected Patients After Highly Active Antiretroviral Therapy
55. Characteristics Of HIV-1 Latent Reservoir In Peripheral Blood With Early HIV-1 Infection And HAART
56. Application Of HIV-1 Antibody Quantitative Detection In Highly Active Antiretroviral Therapy
57. Dynamic Changes And Its Clinical Significance Of HIV-1 DNA In PBMC Of HIV-1 Infected Patients During Highly Active Antiretroviral Therapy
58. The Correlation Between Total HIV-1 Dna And Lymphocyte Count Of HIV Patients Under Highly Active Antiretroviral Therapy
59. Trends in cancer and development of AIDS in HIV-infected individuals before and after implementation of highly active antiretroviral therapy
60. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients
  <<First  <Prev  Next>  Last>>  Jump to